Role of acetaldehyde in the actions of ethanol on the brain — A review

doi:10.1016/0741-8329(95)02026-8

Alcohol

Volume 13, Issue 2, March–April 1996, Pages 147-151

https://doi.org/10.1016/0741-8329(95)02026-8 Get rights and content

Abstract

Over the last 30 years, acetaldehyde has been postulated to mediate various actions of ethanol on the brain. Experiments have studied ethanol consumption after acetaldehyde infusions into the brain, in rodents with high or low activities of hepatic and brain ethanol-metabolizing enzymes, and after treatment with drugs that alter the metabolism of acetaldehyde after ethanol ingestion. Evidence that acetaldehyde is involved in the actions of ethanol has been inconsistent because of the lack of knowledge of the brain acetaldehyde concentrations required to exert their effects, the lack of correlation between the activities of ethanol-metabolizing enzymes across strains of rodents and ethanol consumption, and the lack of specificity of drugs altering acetaldehyde metabolism. The formation of significant amounts of acetaldehyde the brain in vivo after ethanol ingestion and by what mechanism has not been clearly established, although catalase is a promising candidate. Future research needs to directly demonstrate in brain the formation of acetaldehyde in vivo, determine the concentrations in brain areas involved in ethanol consumption, and evaluate the possible actions of drugs other than an ability to block acetaldehyde metabolism.

References (66)

H.K. Anandatheerthavarada et al.
Induction of brain cytochrome P450 IIE1 by chronic ethanol treatment
Brain Res.
(1993)
C.M.G. Aragon et al.
Differences in ethanol-induced behaviors in normal and acatalasemic mice: Systemic examination using a biobehavioral approach
Pharmacol. Biochem. Behav.
(1993)
C.M.G. Aragon et al.
Ethanol-induced motor activity in normal and acatalasemic mice
Alcohol
(1992)
C.M.G. Aragon et al.
Dose- and timedependent effect of an acute 3-amino-1,2,4-triazole injection on rat brain catalase activity
Biochem. Pharmacol.
(1991)
C.M.G. Aragon et al.
Blockade of ethanol-induced conditioned taste aversion by 3-amino-1,2,4-triazole: Evidence for catalase mediated synthesis of acetaldehyde in rat brain
Life Sci.
(1985)
C.M.G. Aragon et al.
Effect of 3-amino-1,2,4triazole on ethanol-induced narcosis, lethality and hypothermia in rats
Pharmacol. Biochem. Behav.
(1991)
C.M.G. Aragon et al.
A correlation between voluntary ethanol consumption and brain catalase activity in the rat
Alcohol
(1985)
G.R. Breese et al.
Antagonism of ethanol narcosis by thyrotropin releasing hormone
Life Sci.
(1974)
Z.W. Brown et al.
Intraventricular self-administration of acetaldehyde and voluntary consumption of ethanol in rats
Behav. Neural Biol.
(1980)
R. Bühler et al.
Immunohistochemical localization of alcohol dehydrogenase in human kidney, endocrine organs and brain
Pharmacol. Biochem. Behav.
(1983)

C.J.P. Eriksson

Ethanol and acetaldehyde metabolism in rat strains genetically selected for their ethanol preference

Biochem. Pharmacol.

(1973)

C.J.P. Eriksson et al.

Evidence against a biphasic effect of acetaldehyde on voluntary ethanol consumption in rats

Pharmacol. Biochem. Behav.

(1980)

M.J. Fregly

Effect of aminotriazole on thyroid function in the rat

Toxicol. Appl. Pharmacol.

(1968)

T.B. Gaines et al.

The toxicity of amitrole in the rat

Toxicol. Appl. Pharmacol.

(1973)

T. Hansson et al.

Regional distribution of ethanol-inducible cytochrome P450 IIE1 in the rat central nervous system

Neuroscience

(1990)

D.J. Heal et al.

Administration of thyrotropin-releasing hormone (TRH) to rats releases dopamine in n. accumbens but not in n. caudatus

Neuropharmacology

(1979)

U.M. Koechling et al.

Effects of 3-amino-1,2,4-triazole on brain catalase in the mediation of ethanol consumption in mice

Alcohol

(1994)

T. Koivisto et al.

Hepatic aldehyde and alcohol dehydrogenases in alcohol-preferring and alcohol-avoiding rat lines

Biochem. Pharmacol.

(1994)

T. Koivula et al.

Liver aldehyde and alcohol dehydrogenase activities in rat strains genetically selected for their ethanol preference

Biochem. Pharmacol.

(1975)

T.J. McCown et al.

Interactions between TRH and ethanol in the medial septum

Pharmacol. Biochem. Behav.

(1986)

S. Morzorati et al.

Septal TRH in alcohol-naive P and NP rats and following alcohol challenge

Brain Res. Bull.

(1993)

D.R. Petersen

Aldehyde dehydrogenase and aldehyde reductase in isolated bovine brain microvessels

Alcohol

(1985)

J.R. Sheppard et al.

Aldehyde dehydrogenase and ethanol preference in mice

J. Biol. Chem.

(1970)

J.D. Sinclair et al.

Suppression of alcohol drinking with brain aldehyde dehydrogenase inhibition

Pharmacol. Biochem. Behav.

(1981)

B.R. Smith et al.

Conditioned place preference induced by intraventricular infusions of acetaldehyde

Alcohol

(1984)

S.M. Socaransky et al.

Brain ALDH as a possible modulator of voluntary ethanol intake

Alcohol

(1985)

D. Steinhoff et al.

Evaluation of amitrole (aminotriazole) for potential carcinogenicity in orally dosed rats, mice, and golden hamsters

Toxicol. Appl. Pharmacol.

(1983)

L. Tampier et al.

Effect of 3-amino-1,2,4-triazole pretreatment on ethanol blood levels after intraperitoneal administration

Alcohol

(1986)

L. Tampier et al.

Effect of 3-amino-1,2,4-triazole on the hypothermic effect of ethanol and on ethanol tolerance development

Alcohol

(1991)

M.B. Waller et al.

Effects of intravenous ethanol and of 4-methylpyrazole on alcohol drinking in alcohol-preferring rats

Pharmacol. Biochem. Behav.

(1982)

M. Warner et al.

Regulation of cytochrome P450 in the central nervous system

J. Steroid Biochem. Mol. Biol.

(1993)

C.M.G. Aragon et al.

The effect of 3-amino-1,2,4-triazole on voluntary ethanol consumption: evidence for brain catalase involvement in the mechanism of action

Neuropharmacology

(1992)

C.M.G. Aragon et al.

Effects of 3-amino1,2,4-triazole on ethanol-induced open field activity: Evidence for brain catalase mediation of ethanol's effects

Alcohol. Clin. Exp. Res.

(1989)

Cited by (147)

Behavioral consequences of the downstream products of ethanol metabolism involved in alcohol use disorder
2022, Neuroscience and Biobehavioral Reviews
Research concerning Alcohol Use Disorder (AUD) has previously focused primarily on either the behavioral or chemical consequences experienced following ethanol intake, but these areas of research have rarely been considered in tandem. Compared with other drugs of abuse, ethanol has been shown to have a unique metabolic pathway once it enters the body, which leads to the formation of downstream metabolites which can go on to form biologically active products. These metabolites can mediate a variety of behavioral responses that are commonly observed with AUD, such as ethanol intake, reinforcement, and vulnerability to relapse. The following review considers the preclinical and chemical research implicating these downstream products in AUD and proposes a chemobehavioral model of AUD.
Acetaldehyde in the brain after ethanol exposure: Research progress and challenges
2019, Neuroscience of Alcohol: Mechanisms and Treatment
Acetaldehyde (ACH) is a potential toxin that is responsible for the complex set of effects observed after ethanol consumption. The liver is the principal site of ACH accumulation after consumption of ethanol. When the ACH concentration becomes too high, the liver is no longer able to process and remove it efficiently. As a result, ACH may persist in other tissues, particularly the brain.
ACH is primarily generated during the metabolism of ethanol. Ethanol misuse can lead to an increased risk of several serious health problems. Several of the effects of ethanol can be attributed to ACH accumulation. Further, ACH is a prooxidant and potential neurotoxin which can alter brain function via several neurotransmitter systems that affect thought processes, behavior, and emotions. ACH toxicity has received far less public attention than has ethanol abuse, owing to the lack of substantial evidence regarding actual ACH concentrations required to exert an effect in the human body after ethanol consumption. However, targeting ACH instead of ethanol could offer a novel approach to reduce excessive ethanol intake, abuse, and ultimately alcoholism. This chapter provides an overview of the generation of ethanol-derived ACH and its toxic effects in the brain, with emphasis on the progress and challenges associated with ACH-related research. Following this overview, we will discuss specific aspects of ACH adducts in the brain.
Induction of brain cytochrome P450 2E1 boosts the locomotor-stimulating effects of ethanol in mice
2014, Neuropharmacology
In the central nervous system ethanol (EtOH) is metabolized into acetaldehyde by different enzymes. Brain catalase accounts for 60% of the total production of EtOH-derived acetaldehyde, whereas cerebral cytochrome P450 2E1 (CYP 2E1) produces 20% of this metabolite. Acetaldehyde formed by the activity of central catalase has been implicated in some of the neurobehavioral properties of EtOH, yet the contribution of CYP 2E1 to the pharmacological actions of this drug has not been investigated. Here we assessed the possible participation of CYP 2E1 in the behavioral effects of EtOH. Thus, we induced CYP 2E1 activity and expression by exposing mice to chronic acetone intake (1% v/v for 10 days) and examined its consequences on the stimulating and uncoordinating effects of EtOH (0–3.2 g/kg) injected intraperitoneally. Our data showed that 24 h after withdrawal of acetone brain expression and activity of CYP 2E1 was induced. Furthermore, the locomotion produced by EtOH was boosted over the same interval of time. Locomotor stimulation produced by amphetamine or tert-butanol was unchanged by previous treatment with acetone. EtOH-induced motor impairment as evaluated in a Rota-Rod apparatus was unaffected by the preceding exposure to acetone. These results indicate that cerebral CYP 2E1 activity could contribute to the locomotor-stimulating effects of EtOH, and therefore we suggest that centrally produced acetaldehyde might be a possible mediator of some EtOH-induced pharmacological effects.
The MAO-A inhibitor clorgyline reduces ethanol-induced locomotion and its volitional intake in mice
2014, Pharmacology Biochemistry and Behavior
Citation Excerpt :
Acetaldehyde is a psychoactive molecule that, when administered centrally mimics with higher potency many of the behavioral (Arizzi-LaFrance et al., 2006; Rodd-Henricks et al., 2002; Sánchez-Catalán et al., 2009) and neurochemical (Diana et al., 2008; Enrico et al., 2009; Foddai et al., 2004) effects produced by EtOH in rodents, but with higher potency. For this reason, it has been postulated that this metabolite could be a mediator of some of the psychopharmacological properties of EtOH (Deitrich, 2004; Deng and Deitrich, 2008; Hipólito et al., 2007; Hunt, 1996; Quertemont et al., 2005; Smith et al., 1997). Thus, it has been demonstrated that many EtOH-related behaviors can be modified by altering the activity of the enzyme catalase in the CNS of rodents.
Hydrogen peroxide is the co-substrate used by the enzyme catalase to form Compound I (the catalase–H₂O₂ system), which is the major pathway for the conversion of ethanol (EtOH) into acetaldehyde in the brain. This acetaldehyde has been involved in many of the effects of EtOH. Previous research demonstrated that treatments that change the levels of cerebral H₂O₂ available to catalase modulate the locomotor-stimulating effects of EtOH and its volitional intake in rodents. However, the source of H₂O₂ which is used by catalase to form Compound I and mediates the psychoactive actions of EtOH is unknown. One cause of the generation of H₂O₂ in the brain comes from the deamination of biogenic amines by the activity of MAO-A. Here we explore the consequences of the administration of the MAO-A inhibitor clorgyline on EtOH-induced locomotion and voluntary EtOH drinking. For the locomotor activity tests, we injected Swiss (RjOrl) mice intraperitoneally (IP) with clorgyline (0–10 mg/kg) and later (0.5–8 h) with EtOH (0–3.75 g/kg; IP). Following these treatments, mice were placed in locomotor activity chambers to measure their locomotion. For the drinking experiments, mice of the C57BL/6J strain were injected IP with clorgyline prior to offering them an EtOH (20%) solution following a drinking-in-the-dark procedure. Additional experiments were performed to assess the selectivity of this compound in altering EtOH-stimulated locomotion and EtOH intake. Moreover, we indirectly tested the ability of clorgyline to reduce brain H₂O₂ levels. We showed that this treatment selectively reduced EtOH-induced locomotion and its self-administration. Moreover, this compound decreased central H₂O₂ levels available to catalase. We suggest that H₂O₂ derived from the deamination of biogenic amines by the activity of MAO-A could determine the formation of brain EtOH-derived acetaldehyde. This centrally-formed acetaldehyde within the neurons of the aminergic system could play a role in the neurobehavioral properties of EtOH.
Influence of chronic ethanol intake on mouse synaptosomal aspartyl aminopeptidase and aminopeptidase A: Relationship with oxidative stress indicators
2012, Alcohol
Citation Excerpt :
This is probably due to free radicals which appear after chronic ethanol intake and are the direct consequence of ethanol action and independent from mitochondrial activity, as has been described by authors that postulate that chronic ethanol intake potentiates free radical generation in the nervous system (Montoliu, Valles, Renau-Piqueras, & Guerri, 1994; Mukherjee, Das, Vaidyanathan, & Vasudevan, 2008). In addition, chronic ethanol consumption may damage the nervous system directly via its oxidative metabolite acetaldehyde (Hunt, 1996) or through non-oxidative metabolites such as fatty acid ethyl esters (de Jersey & Treolar, 1994; Soderberg, Salem, Best, Cluette-Brown, & Laposata, 2003) or phosphatidylethanol (Dodd et al., 2000). The decrease of protein CGC levels after chronic ethanol intake could be a consequence of later modifications which are not related to neurotoxic events, such as structural alterations by enzymatic or non enzymatic glycosylation processes (Levine et al., 1990).
Aminopeptidase A (APA) and aspartyl aminopeptidase (ASAP) not only act as neuromodulators in the regional brain renin-angiotensin system, but also release N-terminal acidic amino acids (glutamate and aspartate). The hyperexcitability of amino acid neurotransmitters is responsible for several neurodegenerative processes affecting the central nervous system. The purpose of the present work was to study the influence of chronic ethanol intake, a well known neurotoxic compound, on APA and ASAP activity under resting and K⁺-stimulated conditions at the synapse level. APA and ASAP activity were determined against glutamate- and aspartate-β-naphthylamide respectively in mouse frontal cortex synaptosomes and in their incubation supernatant in a Ca²⁺-containing or Ca²⁺-free artificial cerebrospinal fluid. The neurotoxic effects were analyzed by determining free radical generation, peroxidation of membrane lipids and the oxidation of synaptosomal proteins. In addition, the bioenergetic behavior of synaptosomes was analyzed under different experimental protocols. We obtained several modifications in oxidative stress parameters and a preferential inhibitor effect of chronic ethanol intake on APA and ASAP activities. Although previous in vitro studies failed to show signs of neurodegeneration, these in vivo modifications in oxidative stress parameters do not seem to be related to changes in APA and ASAP, invalidating the idea that an excess of free acidic amino acids released by APA and ASAP induces neurodegeneration.
Neuropsychological functions in bipolar disorders I and II with and without comorbid alcohol dependence
2012, Progress in Neuro-Psychopharmacology and Biological Psychiatry
Citation Excerpt :
Hence, in comparison with social drinking, ALD may have a more profound attention bias, and cause more profound executive and inhibition dysfunction. Other studies (Crews et al., 2005; Hunt, 1996) have reported that chronic exposure to ethanol may cause brain damage and generate an alteration in brain functions, mentality, and behavior in alcohol-dependent people. Hsiao et al. (2009) reported that BP-I and BP-II patients have different patterns of neuropsychological functioning, and that the neuropsychological function of the BP-II group could remit nearly to that of the HC group.
Bipolar disorder (BP) is a mental disorder most likely to co-occur with substance dependence and abuse, especially alcohol dependence (ALD). Whether the effect of comorbid alcoholism is different between the BP-I and BP-II subtypes remains unclear. We aimed to identify the neuropsychological performance of BP patients with and without comorbid ALD in partial remission from depression or mania, and compare it with that of healthy controls (HCs).
We recruited 29 HCs and 94 BP patients, whom we categorized into four groups: (1) BP-I without a history of alcohol abuse or dependence (BP-I^− ALD; n = 22), (2) BP-II without a history of alcohol abuse and dependence (BP-II^− ALD; n = 38), (3) BP-I with comorbid ALD (BP-I^+ ALD; n = 16), and (4) BP-II with comorbid ALD (BP-II^+ ALD; n = 18). Only males were recruited in this study.
When patients comorbid with ALD were not excluded, there were no significant differences on neuropsychological tests between the BP-I and BP-II groups. However, when patients with comorbid ALD were excluded, there were significant differences between the two BP^− ALD groups. The BP-I^− ALD group had lower scores on memory subtests (p ≤ 0.01) than the HC and BP-II^− ALD groups, but the BP-II^− ALD and HC groups had similar scores.
We found it important to exclude ALD comorbidity when evaluating neuropsychological functions due to our finding that ALD affected the cognitive performance in BP-I more severely than in the BP-II group. ALD not only impairs neuropsychological function, but also worsen the clinical course and leads to a more pernicious status and negative cycle.

View all citing articles on Scopus

View full text

ArticleRole of acetaldehyde in the actions of ethanol on the brain — A review

Abstract

Brain Res.

Pharmacol. Biochem. Behav.

Alcohol

Biochem. Pharmacol.

Life Sci.

Pharmacol. Biochem. Behav.

Alcohol

Life Sci.

Behav. Neural Biol.

Pharmacol. Biochem. Behav.

Biochem. Pharmacol.

Pharmacol. Biochem. Behav.

Toxicol. Appl. Pharmacol.

Toxicol. Appl. Pharmacol.

Neuroscience

Neuropharmacology

Alcohol

Biochem. Pharmacol.

Biochem. Pharmacol.

Pharmacol. Biochem. Behav.

Brain Res. Bull.

Alcohol

J. Biol. Chem.

Pharmacol. Biochem. Behav.

Alcohol

Alcohol

Toxicol. Appl. Pharmacol.

Alcohol

Alcohol

Pharmacol. Biochem. Behav.

J. Steroid Biochem. Mol. Biol.

The effect of 3-amino-1,2,4-triazole on voluntary ethanol consumption: evidence for brain catalase involvement in the mechanism of action

Neuropharmacology

Effects of 3-amino1,2,4-triazole on ethanol-induced open field activity: Evidence for brain catalase mediation of ethanol's effects

Alcohol. Clin. Exp. Res.

Article
Role of acetaldehyde in the actions of ethanol on the brain — A review